CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 99 filers reported holding CYTOMX THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,017,277 | -42.9% | 635,798 | -48.3% | 0.04% | -47.3% |
| Q3 2022 | $1,783,000 | -20.8% | 1,229,545 | 0.0% | 0.07% | -12.9% |
| Q2 2022 | $2,250,000 | -14.0% | 1,229,545 | +25.5% | 0.08% | +6.2% |
| Q1 2022 | $2,617,000 | -38.3% | 980,085 | 0.0% | 0.08% | -32.2% |
| Q4 2021 | $4,244,000 | -22.7% | 980,085 | -9.1% | 0.12% | -23.9% |
| Q3 2021 | $5,488,000 | -19.6% | 1,078,103 | 0.0% | 0.16% | -1.9% |
| Q2 2021 | $6,824,000 | +12.3% | 1,078,103 | +37.2% | 0.16% | +16.2% |
| Q1 2021 | $6,075,000 | +205.6% | 785,899 | +159.0% | 0.14% | +195.7% |
| Q4 2020 | $1,988,000 | +49.4% | 303,465 | +51.6% | 0.05% | +39.4% |
| Q3 2020 | $1,331,000 | – | 200,224 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 5,576,471 | $36,526,000 | 1.44% |
| Altium Capital Management LP | 273,703 | $1,793,000 | 0.67% |
| Jackson Creek Investment Advisors LLC | 80,367 | $526,000 | 0.21% |
| HARBOURVEST PARTNERS LLC | 79,193 | $519,000 | 0.20% |
| XTX MARKETS LLC | 14,169 | $93,000 | 0.19% |
| Perceptive Advisors | 2,577,043 | $16,880,000 | 0.18% |
| RTW INVESTMENTS, LP | 1,527,352 | $10,004,000 | 0.17% |
| Exane Asset Management | 30,568 | $200,220,000 | 0.14% |
| Virtus ETF Advisers LLC | 37,343 | $245,000 | 0.10% |
| Congress Park Capital LLC | 25,807 | $169,000 | 0.10% |